Lightnews — Scholar-powered news

Carolyn Rodriguez

@crodriguezmdphd.bsky.social

610 followers 390 following 27 posts

Posts Media Videos Starter Packs

Pinned

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Sep 2

Thank you @pbs.org Emmy-nominated public TV program "Healthy Minds" for highlighting hoarding disorder on (new) Season 10 Episode 7⭐️Great questions from host & executive producer Dr. Jeff Borenstein; "with help there is hope" @bbrfoundation.bsky.social

www.pbs.org/video/hoardi...

Healthy Minds With Dr. Jeffrey Borenstein | Hoarding Disorder | Season 10 | Episode 7

Cognitive behavior and virtual reality therapies for excessive acquisition, difficulty discarding.

www.pbs.org

4 12

Reposted by Carolyn Rodriguez

Neuropsychopharmacology @npp-journal.bsky.social · 22d

Welcome to new @acnporg.bsky.social Associate Member @drlaramieduncan.bsky.social - we're so happy you're here! #WelcomeToACNP👋

ACNP @acnporg.bsky.social · 22d

Congratulations to Laramie Duncan, Ph.D. a new Associate Member of ACNP! Welcome!! 👋@drlaramieduncan.bsky.social

1 1 2

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Sep 2

Congratulations🌟Dr.🌟 Paula Munoz Rodriguez!! Thank you to my wonderful colleague Lea Williams for co-mentoring Paula's neuroscience PhD w/ me & @pineurosci.bsky.social Xue Zhang Appreciate Paula's committee chair @agoldpie.bsky.social members Drs. Knutson, Hosseini, Moya🙌 & Paula’s classmates

1 5

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Sep 2

Healthy Minds With Dr. Jeffrey Borenstein | Hoarding Disorder | Season 10 | Episode 7

Cognitive behavior and virtual reality therapies for excessive acquisition, difficulty discarding.

www.pbs.org

4 12

Reposted by Carolyn Rodriguez

Cecile Ladouceur, PhD @cdladouceur.bsky.social · Aug 21

Spread the word!! DANS 2025 registration is opening very soon…take a look at some of our amazing speakers! You can present a poster you will present or have presented elsewhere…the goal is to foster discussion. Check dans.pitt.edu for updates!

5 4

Reposted by Carolyn Rodriguez

Leah Mayo @mayoonthebrain.bsky.social · Aug 12

Excited to be co-chairing a panel with @argelaguilarvalles.bsky.social featuring
Sophie Holmes, Ellen Bradley, & Craig Ferris for #ACNP2026 in the Bahamas 😎

1 7 33

Reposted by Carolyn Rodriguez

Uma R. Chatterjee, M.S., MHPS @umarchatterjee.bsky.social · Aug 12

2) I’m honored to be selected as a mentee for the @acnporg.bsky.social Near-Peer Mentorship Program! 🎉

I’m deeply grateful to everyone in our field who has supported me as a scientist with lived experience! I wouldn’t be here without your belief in me & you challenging the stigma! 🙏🏾 #ACNP2026

3 20

Reposted by Carolyn Rodriguez

Uma R. Chatterjee, M.S., MHPS @umarchatterjee.bsky.social · Aug 12

THRILLED to share @acnporg.bsky.social news x2!

1) Our study group “Centering Lived Experience in Psychiatric Neuroscience Research” @ericjnestler.bsky.social @mayaschumer.bsky.social @deffinger.bsky.social @viscidula.bsky.social @noelvest.bsky.social @cahill-lab.bsky.social=ACCEPTED! 🤩 #ACNP2026

3 13 34

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Aug 11

Congratulations @wickedneuro.bsky.social 🎉🎉

Reposted by Carolyn Rodriguez

Ryan Logan @wickedneuro.bsky.social · Aug 11

I’m happy to share that I’m starting a new position as Vice Chair of Translational Research in Psychiatry at University of Massachusetts Chan Medical School Department of Psychiatry and Behavioral Sciences!

6 4 26

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Aug 1

Congratulations @nicoleprovenza.bsky.social 👏👏👏 excited to follow your work!

Reposted by Carolyn Rodriguez

Nicole Provenza @nicoleprovenza.bsky.social · Aug 1

I’m very excited to share that I got the NOA for my first R01 to study approach-avoidance behaviors after DBS for OCD! We have an awesome team: Sameer Sheth, Wayne Goodman, Eric Storch, and Ben Hayden at BCM, and Han Yi at JHU APL. 🧠⚡️@bcmocd.bsky.social @bcmhouston.bsky.social @jhuapl.bsky.social

BCM Neurosurgery @bcmneurosurgery.bsky.social · Aug 1

#NEWS: Dr. @nicoleprovenza.bsky.social is the recipient of a new $3.7m R01 award from the #NIH & #NIMH for her project, "Neurophysiological investigation of the approach-avoidance axis in OCD: applications to neuromodulation" 🧠

#DBS #OCD #DeepBrainStimulation #ObsessiveCompulsiveDisorder #Research

Project Title:
Neurophysiological investigation of the approach-avoidance axis in OCD: applications to neuromodulation

Project Narrative:
Despite FDA approval for deep brain stimulation (DBS) for obsessive-compulsive disorder (OCD) in the form of a Humanitarian Device Exemption, this therapy remains underutilized and poorly understood. Based on the pathologically avoidant phenotype underlying OCD and the pro-approach behavior required to overcome fear-based avoidance, we conceptualize our study of the neurophysiological underpinnings of OCD by tracking behavior and ventral striatum neural activity along the approach-avoidance axis. Doing so would create a foundational understanding of the neurobehavioral effects of DBS that will generalize to other disorders characterized by dysregulation of behavior along the approach-avoidance axis.

$DBS and OCD: Obsessive-compulsive disorder (OCD) has a lifetime prevalence of 2-3% and is a major cause of global disability. OCD is characterized by obsessions (i.e., unwanted intrusive thoughts) and compulsions (i.e., repetitive ritualistic behaviors), and exemplifies a pathologically avoidant phenotype where greater degrees of avoidance are associated with greater symptom severity and treatment resistance. In the 20-40% of OCD patients that are treatment refractory, deep brain stimulation (DBS) of the ventral capsule and ventral striatum (VC/VS) is an effective therapy that achieves significant benefit in 66% of patients. While VC/VS DBS does not acutely relieve OCD symptoms, DBS often produces a “pro-approach” response including an increase in talkativeness, a desire to engage in activities, extroversion, and affiliative behavior. Our central therapeutic hypothesis is that VC/VS DBS achieves eventual benefit in OCD by providing the “boost” in pro-approach behavior that allows individuals to overcome their pathological fear-based avoidance. Thus, we focus on the approach-avoidance axis as one of the critical neurobehavioral axes underlying the pathophysiology of OCD. Our overall goal is to develop a mechanistic understanding of DBS for OCD by rigorously investigating the relationship between clinical symptoms, behaviors (i.e., approachful vs. avoidant), and neurophysiology.$

4 3 14

Reposted by Carolyn Rodriguez

ACNP @acnporg.bsky.social · Jul 21

We are delighted to welcome Dr. Kate Fitzgerald
@KDFitzgerald_MD, professor at @columbiapsych.bsky.social and expert in child and adolescent psychiatry, as the newest Associate Editor at NPP! "Meet the Editor" with Dr. Kate Fitzgerald youtu.be/zDnOFSm9kxg?... via
@YouTube @npp-journal.bsky.social

npp's "Meet the Editor" with Dr. Kate Fitzgerald

YouTube video by NPP Journal

youtu.be

7 11

Reposted by Carolyn Rodriguez

Alex Kwan @alexkwan.bsky.social · Jul 17

We worked so well as a team for the #GRCPsychedelics @vyazovskiy.bsky.social @viditavaidya.bsky.social @melissaherman.bsky.social

and congrats to @theborislab.bsky.social and @mikaelpalner.bsky.social, who will be the future vice-chairs!

Chairs and vice chairs for the Psychedelics GRC

1 10 31

Reposted by Carolyn Rodriguez

Alex Kwan @alexkwan.bsky.social · Jul 17

Great panel this morning on the human and clinical studies of psychedelics -

my impression is we have come a long way in the last few years in terms of design and quantification #GRCPsychedelics

7 19

Reposted by Carolyn Rodriguez

Daria Ricci @daria-ricci.bsky.social · Jul 17

My first time at a GRC had to be #GRCPsychedelics. Drop by my poster today to talk about 5-MeO, Calcium transients and Gamma bands in the anterior insular cortex 🧠🐭

Yoni Couderc @yonicouderc.bsky.social · Jul 15

At #GRCPsychedelics ?
Don’t miss Daria Ricci’s poster (#29) tomorrow and Thursday! She’s a talented PhD student from the Beyeler lab, presenting very cool photometry and in vivo ephys data in the anterior insular cortex, after a single dose of psychedelics 🍄🐭

1 3 7

Reposted by Carolyn Rodriguez

Nate Heller @nate-h-heller.bsky.social · Jul 17

🌈🧠 The Trip Between Bedside and Bench 🌈🧠
Join us at #SfN2025 for a deep dive into cross-species research in psychedelic neuroscience!

🧬 Posters, 🎤 panels, 🔑 keynotes, 🍸 cocktails, and 🥟 tasty apps await.

RSVP, explore speaker profiles, and help spread the word:
👉 hopkinspsychedelic.org/sfn2025

4 11 17

Reposted by Carolyn Rodriguez

Melissa Herman @melissaherman.bsky.social · Jul 15

#GRCPsychedelics 🔥🔥🔥🔥poster session and our first ever Honorary Best PI poster award to @zenbrainest.bsky.social 🤣🤣🤣

1 10 44

Reposted by Carolyn Rodriguez

Anna Beyeler 🐝 @anna-beyeler.bsky.social · Jul 10

👨‍💻 Open PI position in our institute 👨‍💻 !! If you are an expert in Computational Neuroscience and want to start your lab in Bordeaux, contact us !
www.fens.org/careers/job-...
@neuromagendie.bsky.social
@neurobordeaux.bsky.social

45 50

Reposted by Carolyn Rodriguez

Alex Kwan @alexkwan.bsky.social · Jul 14

Good morning! An excellent panel today on the evolving theory for explaining psychedelic drug action #GRCPsychedelics

4 19

Reposted by Carolyn Rodriguez

Stanford Center for Digital Health @stanfordcdh.bsky.social · Apr 18

New research from #StanfordCDH's @jkim-1003.bsky.social & team analyzed 528k patient messages, developing AI to support clinicians with tailored diabetes care. AI is seen as highly useful for education and admin support, but deeper data integration is perceived as risky. go.nature.com/4jKaVKB

2 5

Reposted by Carolyn Rodriguez

Leah Mayo @mayoonthebrain.bsky.social · Jul 11

What do we know about the endocannabinoid system in developmental psychopathology?🤔

Find out in our recent paper, led by @pact-lab.bsky.social postdocs @ryanntansey.bsky.social & @marcdferger.bsky.social + collaborator extraordinaire @hmarusak.bsky.social 👇

<em>Journal of Child Psychology and Psychiatry</em> | ACAMH Pediatric Journal | Wiley Online Library

Background The endocannabinoid (eCB) system, the primary target of cannabis, has gained significant attention as a potential novel therapeutic approach for treating a range of psychiatric disorders ...

acamh.onlinelibrary.wiley.com

7 10

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Jul 12

👏 nicely done!

Reposted by Carolyn Rodriguez

Boris D Heifets @theborislab.bsky.social · Jul 9

How much is the psychedelic experience influenced by what we see, hear and read? We made a way to measure it: The Psychedelic Media Exposure Questionnaire - developed by Audrey Evers, Chris Kelly, @shaylalove.bsky.social , @tehseennoorani.bsky.social, validated on >600 respondents. Link below:

The Psychedelic Media Exposure Questionnaire: The development and validation of a new scale assessing psychedelic-related media exposure

Rationale: A reliable and valid instrument is needed to measure exposure to psychedelic-related media to examine the impact of media and expectations on outcomes in psychedelic clinical trials. Object...

www.medrxiv.org

3 6 11

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Jul 12

BIG thank you to Russ Altman @rbaltman.bsky.social for having me on to Stanford Engineering's The Future of Everything podcast to talk about Hoarding Disorder.
For those w/ loved ones who struggle w hoarding disorder, there is hope and help, including CBT therapy. @IOCDF #OCDCon
youtu.be/mY97ePrY0M4

The future of hoarding disorder

YouTube video by Stanford University School of Engineering

youtu.be

1 3

Carolyn Rodriguez @crodriguezmdphd.bsky.social · Jul 3

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
www.sciencedirect.com/science/arti...

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study

Obsessive-compulsive disorder (OCD) is a common and disabling condition. A large proportion of patients fail to respond to first-line treatment with s…

www.sciencedirect.com

2 6